Evidence map›Paper›PMID 26563116›Full record

ArticlePediatric nephrology (Berlin, Germany)2016

Sevelamer crystals in the mucosa of the gastrointestinal tract in a teenager with end-stage renal disease.

Joseph Kim, Kristin Olson, Lavjay Butani

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Sevelamer-induced Gastrointestinal Mucosal Injury: A Critical Review for Clinicians.Journal of community hospital internal medicine perspectives · 2024
    Review
  3. Article
  4. [Colonic Mass Secondary to Sevelamer-associated Rectal Ulcer].The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2021
    Article
  5. Review
  6. Review
  7. Upper Gastrointestinal Bleeding of Unusual Causation.Digestive diseases and sciences · 2018
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Joseph KimSection of Pediatric Nephrology, Department of Pediatrics , University of California Davis Medical Center, 2516 Stockton Boulevard, Sacramento, CA, 95817, USA.
Kristin OlsonSection of Pediatric Nephrology, Department of Pediatrics , University of California Davis Medical Center, 2516 Stockton Boulevard, Sacramento, CA, 95817, USA.
Lavjay ButaniSection of Pediatric Nephrology, Department of Pediatrics , University of California Davis Medical Center, 2516 Stockton Boulevard, Sacramento, CA, 95817, USA. lbutani@ucdavis.edu.
University of California Davis Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNon-calcium-containing phosphate binders, such as sevelamer preparations, are being increasingly used in patients on dialysis due to their lower association with hypercalcemia and cardiovascular morbidity and mortality. While minor gastrointestinal side effects are quite common with the use of sevelamer, more serious gastrointestinal toxicities have only rarely been reported. CASE-DIAGNOSIS/TREATMENT: We report a pediatric patient on maintenance dialysis receiving sevelamer hydrochloride who developed severe abdominal pain and a high-grade stricture of the sigmoid colon. The patient underwent exploratory laparotomy, resulting in a partial colectomy and colostomy. Histopathologic examination showed colonic mucosal injury and characteristic "fish-scale"-like sevelamer hydrochloride crystals within the mucosa.

conclusionsWhether the sevelamer crystals were causal, contributory or purely incidental remains to be clearly elucidated. However, our case raises sufficient concern to warrant additional investigation into whether there is a causal relationship between sevelamer use and intestinal mucosal injury.

Indexed as

AdolescentChelating AgentsFemaleGastric MucosaGastrointestinal TractHumansKidney Failure, ChronicLaparotomyRenal DialysisSevelamerStomach DiseasesChelating AgentsSevelamerChronic kidney diseaseCrystalGastrointestinal toxicityHyperphosphatemiaSevelamer carbonateSevelamer hydrochloride

Identifiers

PMID26563116
OpenAlexW2173051565

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.